U.S. Markets close in 5 hrs 33 mins

4D pharma plc (LBPSW)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
0.8565+0.0001 (+0.01%)
As of 10:08AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.8564
Open0.8500
Bid0.8810 x 1400
Ask0.8999 x 800
Day's Range0.8565 - 0.8566
52 Week Range0.8565 - 0.8566
Volume3,408
Avg. VolumeN/A
Market CapN/A
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Business Wire

    4D pharma Presents Two Clinical Posters for Live Biotherapeutic MRx0518 at the European Society for Medical Oncology (ESMO) Congress 2021

    LEEDS, England, September 15, 2021--4D pharma plc (AIM: DDDD, NASDAQ: LBPS), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived from the microbiome, today announces new biomarker analyses from two ongoing clinical trials of its lead immuno-oncology single strain Live Biotherapeutic, MRx0518, in both neoadjuvant and refractory solid tumor settings, at the European Society for Medical Oncology (ESMO) Congress, September 16-21, 202

  • Business Wire

    4D pharma to Participate in Upcoming Virtual Investor Conferences in September

    LEEDS, England, September 09, 2021--4D pharma plc (AIM: DDDD, NASDAQ: LBPS), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived from the microbiome, today announces that 4D pharma management will present at the following virtual investor conferences:

  • Business Wire

    4D pharma Announces Two Presentations at European Society for Medical Oncology (ESMO) Congress 2021

    LEEDS, England, August 02, 2021--4D pharma plc (AIM: DDDD, NASDAQ: LBPS), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived from the microbiome, today announces two poster presentations at the European Society for Medical Oncology (ESMO) Congress, held from September 16-21, 2021. The two e-posters will be available from 07:30 BST (02:30 ET) on September 16, 2021.